These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9004975)

  • 21. Efficacy and tolerability of the hormone replacement drug estradiol valerate/levonorgestrel in the treatment of menopausal syndrome in Thai women.
    Chittacharoen A; Domhardt R; Manonai J; Golbs S
    Methods Find Exp Clin Pharmacol; 2003 Oct; 25(8):645-51. PubMed ID: 14671683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormone replacement therapy with estradiol valerate and cyproterone acetate: effects on endothelium-dependent vasodilatation and arterial wall compliance.
    Mares P; Dauzat M; Abramovici Y
    Maturitas; 2002 May; 42(1):45-53. PubMed ID: 12020979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alleviation of the climacteric symptoms with oral sequential hormone replacement therapy.
    Chittacharoen A; Domhardt R; Manonai J; Theppisai U; Golbs S
    J Med Assoc Thai; 2004 Jan; 87(1):1-7. PubMed ID: 14971528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hormonal therapy in perimenopause].
    Zaĭdieva IaZ
    Akush Ginekol (Mosk); 1995; (3):28-30. PubMed ID: 7653724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate.
    Imthurn B; Rosselli M; Jaeger AW; Keller PJ; Dubey RK
    J Clin Endocrinol Metab; 1997 Feb; 82(2):388-94. PubMed ID: 9024224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of two different progestins (cyproterone acetate and norgestrel), administered in a cyclical estradiol valerate regimen, on markers of bone turnover.
    Prelević GM; Beljić T; Balint-Perić L; Petrović J; Elliesen J
    Gynecol Endocrinol; 1994 Sep; 8(3):209-14. PubMed ID: 7847107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cyproterone acetate improves beta-cell function in postmenopausal women with diabetes mellitus type 2].
    Borisova AM; Tankova Ts; Kamenova P; Dakovska L; Kirilov G; Genov N; Kovacheva R; Milcheva B; Koev D
    Akush Ginekol (Sofiia); 2003; 42(5):8-14. PubMed ID: 14682006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrauterine or oral administration of levonorgestrel in combination with estradiol to perimenopausal women--effects on lipid metabolism during 12 months of treatment.
    Andersson K; Stadberg E; Mattsson LA; Rybo G; Samsioe G
    Int J Fertil Menopausal Stud; 1996; 41(5):476-83. PubMed ID: 8934257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progestogens: therapeutic and adverse effects in early post-menopausal women.
    Marslew U; Riis B; Christiansen C
    Maturitas; 1991 Mar; 13(1):7-16. PubMed ID: 1830636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical effects of hormone replacement therapy with estradiol valerate and cyproterone acetate in perimenopausal women].
    Tinelli FG; Tinelli A; Sena T
    Minerva Ginecol; 2002 Feb; 54(1):67-73. PubMed ID: 11828273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence.
    Wierckx K; Van Caenegem E; Schreiner T; Haraldsen I; Fisher AD; Toye K; Kaufman JM; T'Sjoen G
    J Sex Med; 2014 Aug; 11(8):1999-2011. PubMed ID: 24828032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pilot study to evaluate a new regimen to treat climacteric complaints with cyclic combined oestradiol valerate/medroxyprogesterone acetate.
    Hellberg D; Nilsson S
    Maturitas; 1987 Apr; 9(1):103-7. PubMed ID: 2955203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application and factor analysis of the menopause rating scale [MRS] in a post-marketing surveillance study of Climen.
    Schneider HP; Rosemeier HP; Schnitker J; Gerbsch S; Turck R
    Maturitas; 2000 Dec; 37(2):113-24. PubMed ID: 11137330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of cyclic estradiol valerate/levonorgestrel on periclimacteric syndrome and endometrial cytology.
    Castiglione A; Bierschwale M; Novoa O
    Clin Ther; 1985; 7(5):555-8. PubMed ID: 3931915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in serum lipids during treatment with norgestrel, oestradiol-valerate and cycloprogynon.
    Nielsen FH; Honoré E; Kristoffersen K; Secher NJ; Pedersen GT
    Acta Obstet Gynecol Scand; 1977; 56(4):367-70. PubMed ID: 602705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The lipid and clinical effects of sequential transdermal estradiol and estradiol/norethisterone acetate in 674 women.
    Cano A; Calaf J; Molina J
    Arch Gynecol Obstet; 2003 Oct; 268(4):317-22. PubMed ID: 14504877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy on climacteric symptoms of a new estradiol transdermal patch with active matrix in comparison with a reference reservoir patch. Two long-term randomized multicenter parallel-group studies.
    Rovati LC; Schmid K; Giacovelli G; Bonn M; Setnikar I; Wolff F; Genazzani AR
    Arzneimittelforschung; 1999 Nov; 49(11):933-43. PubMed ID: 10604047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid profile during hormone replacement therapy: effect of different progestins?
    Campagnoli C; Belforte P; Di Sario MM; Lesca L
    Zentralbl Gynakol; 1997; 119 Suppl 2():1-6. PubMed ID: 9361391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects on climacteric symptoms, bone and lipoprotein metabolism of hormone replacement therapy delivered by estradiol-releasing intravaginal rings: a pilot study.
    Farish E; Barnes JF; Rankin M; Hart DM
    Climacteric; 2003 Sep; 6(3):211-20. PubMed ID: 14567769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of dysfunctional uterine bleeding in the perimenopause: the effects of adding combined estradiol/norethisterone acetate therapy to goserelin acetate treatment--a randomized, placebo-controlled, double-blind trial.
    Franke HR; Snaaijer FF; Houben PW; van der Mooren MJ
    Gynecol Endocrinol; 2006 Dec; 22(12):692-7. PubMed ID: 17162712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.